BioWorld

Oct. 24, 2001

View Archived Issues

Other News To Note

Read More

Pharmacopeia, Ester Sign Deal To Identify Drug Candidates

Read More

TolerRx Series B Gets $17M To Advance Preclinical Work

Read More

NephRx Growth Factor Work Seeks VC Cash, Collaborator

Read More

TNF Doctrine In Multiple Sclerosis Therapy Disproved – With Caveats – In Knockout Mice Demonstration

Read More

Metabasis Earmarking $19.2M For Liver Cancer Drug Efforts

Read More

Cubist Sells Convertible Notes: $125M For Antibiotic, Others

Read More